Abstract
The MIGRATE (MrI Guided RegenerAtive ThErapy) consortium is a combined scientific and industrial effort to establish an MRIguided intramyocardial injection platform. By collaborating within the MIGRATE consortium we were able to combine state-of-theart interventional imaging hardware, software, MRI-compatible catheters, and biomaterials. In this pilot study, we demonstrated the feasibility of intramyocardial injections of an MRI-visible biomaterial by interventional MRI using a combination of active tracking and passive visualisation.
Original language | English |
---|---|
Pages (from-to) | E336-E339 |
Number of pages | 4 |
Journal | EuroIntervention |
Volume | 15 |
Issue number | 4 |
DOIs | |
Publication status | Published - Jul 2019 |
Bibliographical note
Funding Information:This work was performed at the UMC Utrecht with support from partners of the MIGRATE consortium: Philips Research, University of Technology Eindhoven, CART-Tech, Imricor Medical Systems, Nano4Imaging, Cook Medical, Personal Space Technologies, Netherlands Heart Institute and the Dutch Heart Foundation.
Funding Information:
This work was conducted with financial support from the NHS, ICIN-Netherlands Heart Foundation and partners of the MIGRATE consortium (within the TKI LSH framework).
Publisher Copyright:
© 2019 Pensoft Publishers. All rights reserved.